Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- New Takeda Global Headquarters Designed for LGBT Inclusion
July 9, 2018
- Shionogi Regains Exclusive US Rights to Symproic, Seeking New Partner
July 9, 2018
- No Drug Breaks 100 Billion Yen Mark in FY2017 Japan Sales Ranking: Jiho Tally
July 6, 2018
- Use of Digital Health Apps Could Reduce Medical Expenditure by 339 Billion Yen Annually: IQVIA
July 6, 2018
- Sumitomo Dainippon Files Thiotepa for Conditioning Regimen Prior to Autologous HSCT in Pediatric Solid Tumors
July 5, 2018
- Pfizer Wringing Hands over PMP Eligibility for Lorlatinib; It Might Earn 1st Conditional OK, but It’s “4th” ALK Inhibitor
July 5, 2018
- Meiji Holdings Makes Kaketsuken’s Successor Company Its Consolidated Subsidiary
July 4, 2018
- Single-Dose Flu Drug Xofluza Filed in Taiwan: Shionogi
July 3, 2018
- Takeda Celebrates Grand Opening for New Global Headquarters
July 3, 2018
- JCR Launches PIII Study of Growject for SHOX Deficiency
July 3, 2018
- Sawai President Shows Eagerness to “Take Over” To-Be-Withdrawn LLPs
July 2, 2018
- With Focus on CGRP, Development of New Generation of Preventive Treatments for Migraines Heating Up
July 2, 2018
- Baxalta Appeals to IP High Court in Hemlibra Patent Lawsuit against Chugai
July 2, 2018
- Weber Earns 1.2 Billion Yen in FY2017, Logging Western-Level Pay Ratio
June 29, 2018
- Grilled by Shareholders, Takeda CEO Seeks Understanding for Shire Deal
June 29, 2018
- AstraZeneca, MSD to Copromote Lynparza from July
June 29, 2018
- Nippon Shinyaku’s Sakigake-Designated DMD Med Boosts Dystrophin Protein Production in Clinical Studies
June 29, 2018
- BMS Ties Up with Nagoya Univ. for Immuno-Oncology Biomarker Research
June 29, 2018
- Eliquis Significantly Lowers Stroke Risk vs Warfarin: Real-World Data
June 29, 2018
- Mitsubishi Tanabe, Janssen Revise Copromotion Framework for Stelara
June 29, 2018
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…